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Abstract
Background: It is important to determine if rates of survival and major neurodevelopmental
impairment in extremely low gestational age newborns (ELGANs; infants born at 23–27 weeks
gestation) are changing over time.
Methods: Study infants were born at 23 to 27 weeks of gestation without congenital anomalies at
a tertiary medical center between July 1, 1990 and June 30, 2000, to mothers residing in a thirteen-
county region in North Carolina. Outcomes at one year adjusted age were compared for two
epochs of birth: epoch 1, July 1, 1990 to June 30, 1995; epoch 2, July 1, 1995 to June 30, 2000. Major
neurodevelopmental impairment was defined as cerebral palsy, Bayley Scales of Infant Development
Mental Developmental Index more than two standard deviations below the mean, or blindness.
Results: Survival of ELGANs, as a percentage of live births, was 67% [95% confidence interval: (61,
72)] in epoch 1 and 71% (65, 75) in epoch 2. Major neurodevelopmental impairment was present
in 20% (15, 27) of survivors in epoch 1 and 14% (10, 20) in epoch 2. When adjusted for gestational
age, survival increased [odds ratio 1.5 (1.0, 2.2), p = .03] and major neurodevelopmental
impairment decreased [odds ratio 0.54 (0.31, 0.93), p = .02] from epoch 1 to epoch 2.
Conclusion:  The probability of survival increased while that of major neurodevelopmental
impairment decreased during the 1990's in this regionally based sample of ELGANs.
Background
During the 1980's and early 1990's, improvements in
perinatal care resulted in an increased rate of survival for
extremely low gestational age newborns (ELGANs; infants
23–27 weeks) [1]. Despite some evidence that increased
survival of ELGANs may be accompanied by an increased
rate of disability [2,3], most reports suggest that this is not
the case [4-8]. Continuing increases in the rate of survival
of extremely premature infants have been reported during
the late 1990's [9,10], but more information is needed
regarding changes in outcome related to improved sur-
vival.
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The aim of the study was to investigate whether survival in
a geographically based sample of ELGANs increased dur-
ing the 1990's, and if so, whether this increase was accom-
panied by an increased rate of major neurodevelopmental
impairments among survivors.
Methods
This study was approved by the Institutional Review
Boards at Wake Forest University Health Sciences and For-
syth Medical Center with a waiver of informed consent.
Subjects
We reviewed delivery log books at Forsyth Medical Center,
the only tertiary level obstetric referral center in a thirteen-
county region of western North Carolina, to identify
babies born alive at 23 to 27 weeks gestation to mothers
residing in this region. Babies were included in the study
if they had an Apgar score at any time >0, date of birth
between July 1, 1990 and June 30, 2000, and no major
congential malformations or chromosomal syndromes.
To determine the completeness of our ascertainment of a
regionally based cohort of babies born at 23–27 weeks of
gestation, we obtained, from the North Carolina Center
for Health Statistics, the number of fetal deaths and live
births, at 23–27 weeks gestation, that occurred at our peri-
natal referral center and at other hospitals in North Caro-
lina, between July 1, 1995, and June 30, 2000, to mothers
residing in the geographical region from which our sam-
ple was drawn. (Comparable data were not available to us
for 1990 to 1994.) Based on these data, 79% of all
ELGANs born to mothers residing in the geographical
region which our sample represents were born at our peri-
natal referral center, and 96% of these inborn infants were
identified by reviewing the delivery log books and were
included in this study.
Neonatal data
We obtained the following data from an electronic data-
base: birth weight, gestational age, race, gender, delivery
route, level of maternal education, days treated with ven-
tilation, presence of pneumothorax or pulmonary intersti-
tial emphysema, days treated with supplemental oxygen,
cranial ultrasound findings, and receipt of postnatal ster-
oids. The sources of these data were hospital admission
and discharge summaries and radiologists' reports about
ultrasound findings. These data were entered into an elec-
tronic database by a research assistant at hospital dis-
charge.
Follow up data
All survivors were enrolled in an Infant Follow up Project,
which was begun in 1976 and has operated continuously
since that time. At 12 months adjusted age, children were
scheduled for a multidisciplinary evaluation which
included an assessment of deep tendon reflexes, passive
muscle tone, posture, postural reflexes, and gross and fine
motor function. This examination was performed by a
neonatologist with special interest in follow up, a devel-
opmental pediatrician, or a pediatric resident supervised
by either a developmental pediatrician or a neonatologist.
Pediatricians were aware of infants' medical histories. The
evaluation also included the Bayley Scales of Infant Devel-
opment (BSID), administered by a child psychologist, or
a psychology graduate student supervised by a doctoral
level child psychologist, who was not aware of the child's
medical history. The clinical psychologists were informed
of the gestational age only after testing was completed.
Prior to October 1993, the BSID- First Edition, were used.
After that, the BSID- Second Edition were used. Based on
a study of premature infants assessed concurrently with
the BSID- First Edition and the BSID- Second Edition, we
subtracted seven points from the mental developmental
index (MDI) of those infants assessed with the BSID- First
Edition [11].
Definitions
The assignment of gestational age (GA) in completed
weeks (i.e., 23 0/7 to 27 6/7) weeks was based on the date
of the mother's last menstrual period unless this was not
available, in which case an obstetrician's best estimate
based on first trimester ultrasound when available, other-
wise a late ultrasound was used. Infrequently, no prenatal
estimate was available, and in such cases, GA was based
on an assessment of the neonate [12]. Infants who did not
receive assisted ventilation and died on the first day of life
were classified as having "not received intensive care". The
definition of fetal death in North Carolina is death, indi-
cated by the lack of breathing or other evidence of life
such as beating of the heart, pulsation of the umbilical
cord, or definite movement of voluntary muscles, prior to
complete expulsion or extraction from its mother of a
product of human conception that results from pregnan-
cies of 20 or more weeks gestation. Race was defined as
mother's stated race. Infants were classified as small for
gestational age (SGA) based on data reported by Kramer
[13]. Chronic lung disease was defined as the use of sup-
plemental oxygen at 36 weeks post menstrual age [14].
"Air leak" was defined as the finding of pneumothorax or
pulmonary interstitial emphysema on chest radiograph.
Cranial ultrasounds were routinely obtained at 7–14 days
of age and repeated every 1 to 2 weeks if abnormal. Major
cranial ultrasound abnormality was defined as either 1)
complicated periventricular hemorrhage (subependymal/
intraventricular hemorrhage associated with hydrocepha-
lus requiring shunt placement, or persistent but non pro-
gressive ventricular dilation); or 2) periventricular
intracerebral echodensity, echolucency, or persistent ven-
tricular enlargement [15,16]. Infants were classified based
on their worst cranial ultrasound findings. Delayed men-
tal development was defined as a Bayley MDI more thanBMC Pediatrics 2007, 7:20 http://www.biomedcentral.com/1471-2431/7/20
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two standard deviations (SD) below the mean, after cor-
rection for gestational age at birth. Cerebral palsy was
defined as a non-progressive abnormality of movement
and posture, with increased tone and stretch reflexes in
one or more extremities [17]. Blindness was defined as an
ophthalmologist's statement that the child was blind. A
major neurodevelopmental impairment was defined as
either cerebral palsy, delayed mental development (MDI
> 2 SD below the mean), or blindness. Survival was
defined as survival to one year adjusted age. Information
about postdischarge deaths was obtained from a variety of
sources, including parents, local physicians and public
health nurses, and hospital records. Epoch 1 was defined
as the interval between July 1, 1990 and June 30, 1995;
and epoch 2 as the interval between July 1, 1995 and June
30, 2000.
Clinical practices
Regionalization of maternal transports to Forsyth Medical
Center, the perinatal referral center where infants were
born, was established during the 1970's. Infants with
signs of life were typically resuscitated. Exceptions to this
policy included infants with major congenital anomalies
or infants thought to be less mature than the perceived
limit of viability which was 23 weeks. During epoch 1 an
increasing rate of fetuses of 23 weeks gestational age were
monitored in labor and actively resuscitated. Although
data on exposure to antenatal steroids were not collected,
in other research studies from our medical center, the fre-
quency of antenatal steroid exposure was 19% early in
epoch 1[18], about 60% in 1995[19], and 75% in epoch
2 [20].
Data analyses
Groups were compared using the Wilcoxon rank sum test
and chi square test for, respectively, continuous and
dichotomous variables. Exact 95% confidence intervals
for proportions were computed using EXACTBIN [21]. To
adjust for gestational age, stratified analyses were per-
formed and the results were expressed as Mantel- Haen-
szel summary odds ratios [22]. Multivariate logistic
regression models were also used to estimate adjusted
odds ratios. To adjust for gestational age and other poten-
tial confounders (selected based on an association with
the outcome at α < 0.05), we used logistic regression mod-
els with backwards stepwise elimination of non-signifi-
cant variables. StatXact (Cytel Software Corporation,
Cambridge, Massachusetts) was used for stratified analy-
sis, computation of unadjusted odds ratios and their 95%
confidence limits, and chi square tests for trend. PC-SAS
(SAS Institute Inc., Cary, NC) was used for all other anal-
yses. All of the odds ratios presented below represent the
odds of the outcome in epoch 2 divided by the odds of the
outcome in epoch 1 (i.e., oddsepoch2/oddsepoch1).
Results
Study subjects
As shown in figure 1, six hundred and sixty six infants met
study inclusion criteria. Seventy one ELGANs (epoch 1 =
36, epoch 2 = 35) were born to mothers residing in the
defined region and met all inclusion criteria except that
they were born in referring hospitals. The results of analy-
ses which included these infants led to the same conclu-
sions as those which included only infants born at our
tertiary medical center. Only the latter are presented here.
Neonatal factors known to affect survival did not differ in
epochs 1 and 2 (Table 1). There was a trend (p = 0.09)
toward increased provision of intensive care during epoch
2 which became significant after adjusting for gestational
age (p = 0.01). Of the 458 surviving infants, 187 (90%) in
epoch 1 and 214 (85%) in epoch 2 were seen for a multi-
disciplinary evaluation at 1 year adjusted age. Of the 57
infants who were not seen at 1 year adjusted age, 21 were
lost to follow up and 36 were evaluated by other means
(another Developmental Evaluation Clinic, primary care
physician, or telephone interview).
Survival
In Table 2 survival to one year adjusted age (as a percent-
age of live born infants) is presented by gestational age for
epochs 1 and 2. In comparing the first and second epochs,
survival of ELGANs, as a percentage of live births, was
67% [95% confidence interval: (61, 72)] in epoch 1 and
71% (65, 75) in epoch 2. Survival increased with increas-
ing gestational age in epochs 1 and 2 (p = 0.002 and p <
0.00001, respectively; chi square test for trend). When
adjusted for gestational age, the odds of survival increased
in epoch 2 [odds ratio: 1.5 (1.0, 2.2), p = .03]. When
adjusted for gestational age and the two other prenatal
factors which were associated with survival (i.e., female
gender and small for gestational age), an identical odds
ratio and 95% confidence interval was obtained.
Neurodevelopmental outcomes
Table 3 allows comparison of those seen for follow up
examination at 1 year adjusted age with those not seen for
both epochs 1 and 2 with respect to factors known to
affect neurodevelopmental outcome. Epoch 2 infants
more often had major cranial ultrasound abnormalities (p
= 0.08), but for all other comparisons p > 0.1. Of the 36
infants who were evaluated by means other than a visit to
our follow up clinic, 7 were felt to have developmental
impairment (Epoch 1: 2/13; Epoch 2: 5/23). Analyses
which included data from these infants gave results that
were very similar to those described below.
The MDI on the BSID were similar in epochs 1 and 2
[median score (5th, 95th percentiles); epoch 1: 96 (50,
121); epoch 2: 93 (50, 115). The percentages of children
with MDI > 2 SD below the mean did not differ for theBMC Pediatrics 2007, 7:20 http://www.biomedcentral.com/1471-2431/7/20
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Flow diagram of patients Figure 1
Flow diagram of patients.
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two epochs [epoch 1: 12% (8, 19); epoch 2: 10% (6, 15);
odds ratio: 0.8 (0.4, 1.4)]. Similarly, no significant differ-
ences were found comparing the proportions in the two
epochs with cerebral palsy [epoch 1: 12% (8, 17); epoch
2: 8% (5, 14); odds ratio: 0.7 (0.4, 1.4)] or blindness
[epoch 1: 3% (1, 6); epoch 2: 1% (0, 3); odds ratio: 0.3
(0.1, 1.8)].
Major neurodevelopmental impairment
Of the 69 children classified as having major neurodevel-
opmental impairment, 24 infants had MDI > 2 SD below
the mean without other impairments, 19 infants had cer-
ebral palsy without other impairments, 5 infants were
blind, 19 infants had both cerebral palsy and MDI > 2 SD
below the mean, and 2 infants had all three impairments.
Rates of major neurodevelopmental impairment (as a per-
centage of survivors seen at 1 year adjusted age) are pre-
sented in Table 4. Major neurodevelopmental
impairment was present in 20% (15, 27) of survivors in
epoch 1 and 14% (10, 20) in epoch 2 [odds ratio: 0.7 (0.4,
1.1; p = 0.1]. Gestational age was strongly associated with
the risk of major developmental impairment (chi square
test for trend p < 0.001). When adjusted for gestational
age, infants born in epoch 2 were at lower risk of neurode-
velopmental impairment [adjusted odds ratio 0.54 (0.31,
0.91); p = 0.02]. When adjusted for gestational age and
the other prenatal factor associated with neurodevelop-
mental impairment (i.e., female gender) birth in epoch 2
was associated with a lower risk of impairment [adjusted
odds ratio: 0.6 (0.3, 1.0); p = 0.06]. Further, when
adjusted for gestational age, female gender, and the post-
natal factors associated with impairment (i.e., chronic
lung disease, major cranial ultrasound abnormality,
severe retinopathy of prematurity, and airleak) the associ-
ation between birth in epoch 2 and a lower risk of impair-
ment persisted [adjusted odds ratio: 0.4 (0.2, 0.8); p =
0.008]. Odds ratio for the neonatal morbidities associated
with developmental impairment were as follows: airleak:
2.4 (1.0, 5.4); severe retinopathy of prematurity: 4.1 (2.0,
8.7); and major cranial ultrasound abnormality: 19.2
(8.4, 43.8). Considering three major predictors of devel-
opmental outcomes in extremely premature infants (i.e.,
severe cranial ultrasound abnormality, chronic lung dis-
ease, and severe retinopathy of prematurity), [23] among
infants with 0, 1, 2, or 3 of these morbidities the percent-
ages (5th, 95th confidence interval) classified as having
major neurodevelopmental impairment at 1 year adjusted
age were 8% (5, 13), 15% (10, 21), 59% (43, 73), and
75% (19, 99), respectively.
Discussion
In this study of a regionally based sample of ELGANs, sur-
vival increased and rates of major developmental impair-
ment detectable at 1 year adjusted age decreased during
the 1990's. During this time there was a trend toward
Table 1: Comparison of Epochs 1 and Epoch 2: Characteristics of extremely low gestational age newborns.
Attribute Epoch 1 (n = 310) Epoch 2 (n = 356) p value
Birth weight, g* 785 (513, 1145) 760 (475, 1140) 0.1
GA, weeks*† 26 (23, 27) 25 (23, 27) 0.2
SGA‡ 9% 9% 0.8
Female 49% 51% 0.6
Non-white 45% 50% 0.2
Multiple gestation 11% 16% 0.1
C-section 42% 47% 0.2
No resuscitation 9% 6% 0.09
*expressed as median (5th, 95th percentiles)
†GA, gestational age
‡SGA, small for gestational age based on data reported by Kramer [13]
Table 2: Gestational age-specific survival rates to 1 year adjusted age in Epochs 1 and 2.
Epoch 1 Epoch 2
n % survival (95% CI) n % survival (95% CI)
23 weeks 36 11 (3, 26) 53 25 (14, 38)
24 weeks 50 44 (30, 59) 72 60 (47, 71)
25 weeks 63 68 (55, 79) 57 70 (57, 82)
26 weeks 80 85 (75, 92) 89 84 (75, 91)
27 weeks 81 86 (77, 93) 85 94 (87, 98)
23–27 weeks 310 67 (61, 72) 356 71 (65, 75)BMC Pediatrics 2007, 7:20 http://www.biomedcentral.com/1471-2431/7/20
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increased provision of intensive care to ELGANs.
Although evidence exits that increased provision of inten-
sive care can lead to an increased rate of cerebral palsy
among survivors [2], our study provides reassurance
about the consequences of intensive care for ELGANs who
are born in a tertiary level obstetric center. Our objective
was to describe the change in frequency of adverse neu-
rodevelopmental outcome that accompanied the increase
in survival of extremely low gestational age newborns dur-
ing the late 1990's. Because infants who are born outside
of our tertiary obstetric referral center do not receive the
full benefits of specialized obstetric care, such infants were
excluded from our analysis.
There have been few studies of mortality in extremely low
gestational age babies and to our knowledge no studies of
a geographically based cohort in North America during
the 1990's. The survival rate described here is higher than
that of two cohorts born in Australia and the British Isles.
Doyle et al report a survival rate of 56% (at 5 years of age)
in an Australian cohort of infants born at 23–27 weeks
gestational age in 1991 to 1992 [24]. In the study by
Wood et al, the survival rate among infants born at 23 to
25 weeks in the British Isles in 1995, was 29% [25]. For
comparable groups of infants in our study the survival
rates, respectively, were 67% and 50%. The higher survival
rates reported here might be attributable to several factors,
including our exclusion of infants with congenital anom-
alies, and, more importantly, to the more frequent provi-
sion of intensive care to our cohort (91% versus 84% and
86% versus 75% for comparable groups of infants)
[24,25]. The survival rate reported here for infants born at
23–26 weeks (63% survival) is similar to that of a compa-
rable group born 1996 to 1997 in The Netherlands (65%
survival) [26].
Comparisons with regard to developmental impairment
are more difficult due to differences in the definitions of
Table 3: Attributes of infants who survived to 1 year adjusted age in Epochs 1 and 2.
Epoch 1 (n = 207)* Epoch 2 (n = 251)*
Seen (n = 187) Not Seen (n = 20) Seen (n = 214) Not Seen (n = 37)
Postnatal steroids 27 (14) 0 30 (14) 3 (8)
Airleak† 23 (12) 0 21 (10) 4 (11)
Chronic lung disease‡ 81 (43) 4 (20) 91 (43) 9 (24)
CUS abnormality§ 13 (7) 1 (5) 28 (13) 1 (3)
Non-white 88 (47) 9 (45) 101 (47) 12 (57)
Severe ROP|| 23 (12) 1 (5) 30 (14) 4 (11)
Multiple gestation 11 (6) 3 (15) 48 (22) 2 (5)
Mother married 102 (55) 8 (40) 107 (50) 12 (32)
Maternal education¶
< High School 35 (21) 39 (23)
High School 73 (45) 63 (36)
> High School 55 (34) 71 (41)
* Data presented as number of infants (percentages of group).
† Pneumothorax or pulmonary interstitial emphysema
‡ Use of supplemental oxygen at 36 weeks postmenstrual age
§ Cranial ultrasound abnormality: post-hemorrhagic hydrocephalus; persistent ventricular dilation; intraparenchymal echolucency
|| Severe ROP, retinopathy of prematurity requiring surgery
¶ Maternal education data were available for 163 Epoch 1 subjects and 173 Epoch 2 subjects who were seen at 12 months adjusted age
Table 4: Rates of major neurodevelopmental impairment* detectable at 1 year adjusted age in Epochs 1 and 2.
Epoch 1 Epoch 2
# seen/# survivors (%) % impaired (95% CI) # seen/# survivors (%) % impaired (95% CI)
23 weeks 4/4 (100) 0 (0, 60) 11/13 (85) 73 (39, 94)
24 weeks 22/22 (100) 41 (21, 64) 39/43 (91) 26 (13, 42)
25 weeks 41/43 (95) 15 (6, 29) 36/40 (90) 6 (1, 19)
26 weeks 63/68 (93) 22 (13, 34) 63/75 (85) 11 (5, 22)
27 weeks 57/70 (80) 16 (7, 28) 65/80 (81) 6 (2, 15)
23–27 weeks 187/207 (90) 20 (15, 27) 214/251 (85) 14 (10, 20)
* Major neurodevelopmental impairment in infants seen in our follow up clinic: cerebral palsy, Bayley Scales of Infant Development Mental 
Development Index >2 SD below the mean, or blindnessBMC Pediatrics 2007, 7:20 http://www.biomedcentral.com/1471-2431/7/20
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developmental impairment and the ages at which assess-
ments were obtained. The rates of major developmental
impairment described here are similar to those for compa-
rable groups born in Australia and the British Isles. In the
Australian study [24], 20% of ELGANs had a major disa-
bility at five years of age (blindness, deafness requiring
hearing aids, cerebral palsy affecting the ability to walk, or
intelligence quotient score more than 2 SD below the
mean), and in the British Isles study [25], 23% of survi-
vors had a severe disability at 30 months (physical assist-
ance needed to perform daily activities). Our rates for
comparable groups were 18% and 23%, respectively. The
higher rate of impairment reported by Rijken et al [26]
(36%) is likely due to the classification of infants as
impaired if they had cerebral palsy, BSID-MDI more than
2 SD below the mean, or a BSID psychomotor develop-
mental index more than 2 SD below the mean; the last of
these criteria was not used in our study. Further, the sam-
ple size for that study (36 infants) was small, resulting in
a wide 95% confidence interval for the risk estimate (21%
to 54%).
We are aware of only two studies of changes in survival
and outcome over time of recently born cohorts of
ELGANs [10,27]. Our finding that survival increased dur-
ing the 1990's is consistent with the study by Hoestra et al,
who found that survival for infants born at 23 and 24
weeks increased from 56% in 1991–95 to 75% in 1996–
2000 [10]. The higher survival rates than those reported
here for comparable groups (30% in epoch 1 and 45% in
epoch 2) could be due in part to their more aggressive
delivery room care (only 2% of infants died in the delivery
room) and to not including post discharge deaths. Our
findings differ from those reported by Hintz et al. in a
multicenter study of 839 infants born before 25 weeks
gestation, in which survival rates for those born 1993–96
(40.4% survival) and 1996–99 (43.2% survival) were not
significantly different [27]. In that multicenter study, no
decrease was found in the rate of neurodevelopmental
impairment, and in fact the proportion of infants with
MDI more than 2 SD below the mean increased from 40%
in 1993–96 to 47% in 1996–99. Important differences
between the two studies are the smaller sample size in the
current study, which limits the precision of the estimates,
and the use of a geographically based sample, which lim-
its bias due to changes in referral patterns. Our finding of
improved survival in the late 1990s is consistent with a
recent report of by Wilson-Costello et al in which neu-
rodevelopmental outcome at 20 months adjusted age
improved in the interval 2000–02, as compared to 1990–
99, in a single center cohort of 982 infants with birth
weight less than 1000 grams [28].
In the study by Wilson-Costello, improved outcome
appeared to be due in part to more frequent use of ante-
natal steroids and Cesarean delivery, and a decreased fre-
quency of sepsis, severe cranial ultrasound abnormality,
and postnatal steroid use [28]. In the current study the
rates of Cesarean delivery and severe cranial ultrasound
abnormality did not change. The proportion of our cohort
exposed to postnatal steroid (14%) was considerably
lower than the range reported by others in the 1990s (40–
79%) [3,24,26,27]. Data about sepsis were not available
to us. It seems likely that some of the improvement in sur-
vival which we observed was due to increased provision of
intensive care in the late 1990s. Increased use of antenatal
steroids could have contributed both to improved survival
as well as improved neurodevelopmental outcome.
The current study is based on the experience in a small
geographic area; larger regional studies will be more
informative about the outcome of ELGANs. Another lim-
itation is that the estimates of gestational age that were
used for this study were not based on prospectively devel-
oped criteria. A third limitation of this study is that data
about chorioamnionitis and antenatal steroids were not
available. These prenatal factors have been associated
with, respectively, higher and lower rates of neurological
impairment [29,30]. We are able to estimate based on
other published studies from our nurseries that the expo-
sure of very low birth weight infants to antenatal steroids
increased from 19% prior to the NIH Consensus state-
ment recommending their use [31] to 75% in 2000.
A potential source of bias in the present study derives
from the use of the first edition of the BSID from 1990–
93, and the use of the second edition of that test after
October 1993. Adjustment of the MDIs [11] obtained
with the first edition of the BSID classified 3 additional
infants as neurodevelopmentally impaired in epoch 1.
Another possible bias is expectation bias, referring to the
possibility that clinicians identify neurological abnormal-
ities more often in infants with abnormalities on cranial
ultrasound.
Neurodevelopmental assessments at twelve months
adjusted age are strongly predictive of the presence or
absence of major developmental impairments persisting
at least through eight years of age [32]. However, Hack et
al found that of 78 extremely low birth weight infants(i.e.
birth weight < 1000 g) who had a Bayley MDI < 70 at 20
months adjusted age, only 37% were found to have men-
tal retardation (i.e. an intelligence quotient < 70) when
assessed at eight years of age [33]. Thus it should be noted
that 35% of infants with major neurodevelopmental
impairments were attributable to MDI > 2 SD below the
mean without other impairments. Impairments that are
less severe than those studied here (e.g., learning disabili-
ties) can influence a child's adaptive development, school
success, and quality of life [34]. In these regards our studyBMC Pediatrics 2007, 7:20 http://www.biomedcentral.com/1471-2431/7/20
Page 8 of 9
(page number not for citation purposes)
is not as informative as would be a study of outcome at
school age.
Conclusion
Despite these limitations, this study provides evidence
that the increasing survival rate, during the 1990's, of
infants born at 23–27 weeks gestation was associated with
a decrease in the rate of major neurodevelopmental
impairment. However, the rate of these problems remains
high. Guided by the American Academy of Pediatrics,
Committee on Fetus and Newborn statement concerning
care at the threshold of viability [35], we continue to
aggressively resuscitate many infants born at 23 weeks ges-
tation, but we recognize the paucity of data about the long
term outcome of such infants. Continued study of the out-
come of ELGANs is needed to inform our efforts to coun-
sel parents facing an extremely premature delivery and our
efforts to prevent neurodevelopmental impairment in this
population.
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